TollovidDaily | Financial Buzz

Tag: TollovidDaily

post-image
Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

Breaking News: Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim

Author financial buzzPosted on
17034
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received a new certificate of free sale...
post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Market Research Study & 50% Price Reduction

Author financial buzzPosted on
17418
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th,...
post-image
Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022

Author financial buzzPosted on
18407
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received an Institutional Review Board (IRB) waiver...
post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Purchase Order for 50,000 Tollovid Daily

Author financial buzzPosted on
4899
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner...
post-image
Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece

Author financial buzzPosted on
2618
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease biology-focused joint venture partner NLC Pharma, Ltd., today announced it has...
post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Launches Tollovid Daily Subscription

Author financial buzzPosted on
1966
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
post-image
Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Receives FDA Certificate for Tollovid Daily

Author financial buzzPosted on
6242
FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor...